Aurinia Pharmaceuticals (AUPH) Accumulated Depreciation & Amortization: 2018-2025
Historic Accumulated Depreciation & Amortization for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Sep 2025 value amounting to $4.9 million.
- Aurinia Pharmaceuticals' Accumulated Depreciation & Amortization fell 0.57% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.4 million, marking a year-over-year increase of 17.91%. This contributed to the annual value of $19.4 million for FY2024, which is 66.95% up from last year.
- Aurinia Pharmaceuticals' Accumulated Depreciation & Amortization amounted to $4.9 million in Q3 2025, which was up 0.02% from $4.9 million recorded in Q2 2025.
- Aurinia Pharmaceuticals' 5-year Accumulated Depreciation & Amortization high stood at $4.9 million for Q3 2024, and its period low was $346,000 during Q1 2021.
- Over the past 3 years, Aurinia Pharmaceuticals' median Accumulated Depreciation & Amortization value was $4.8 million (recorded in 2024), while the average stood at $3.7 million.
- Examining YoY changes over the last 5 years, Aurinia Pharmaceuticals' Accumulated Depreciation & Amortization showed a top increase of 367.04% in 2021 and a maximum decrease of 94.10% in 2021.
- Over the past 5 years, Aurinia Pharmaceuticals' Accumulated Depreciation & Amortization (Quarterly) stood at $836,000 in 2021, then surged by 74.04% to $1.5 million in 2022, then skyrocketed by 31.27% to $1.9 million in 2023, then surged by 154.55% to $4.9 million in 2024, then decreased by 0.57% to $4.9 million in 2025.
- Its last three reported values are $4.9 million in Q3 2025, $4.9 million for Q2 2025, and $4.9 million during Q1 2025.